Drug ID: | NPD6991 |
Drug Name: | |
Molecular Formula: | C28H28BrFN2O2 |
Canonical SMILES: | COc1nc2ccc(cc2cc1[C@H]([C@](c1cccc(c1)F)(CCN(C)C)O)c1ccccc1)Br |
Standard InCHI: | InChI=1S/C28H28BrFN2O2/c1-32(2)15-14-28(33,21-10-7-11-23(30)18-21)26(19-8-5-4-6-9-19)24-17-20-16-22(29)12-13-25(20)31-27(24)34-3/h4-13,16-18,26,33H,14-15H2,1-3H3/t26-,28-/m1/s1 |
Standard InCHIKey: | TZNZMTAIOJDNJP-IXCJQBJRSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNAP001692 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 5746640 |
ChEBI | |
CAS Number |
Molecular Weight | 522.13 |
ALogP | 0.5114 |
MLogP | 3.88 |
XLogP | 8.325 |
HDA | 3 |
HBD | 1 |
Rotatable Bonds | 14 |
TPSA | 45.59 |
RO5 Violation | 1 |